These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

703 related articles for article (PubMed ID: 19157505)

  • 1. Diagnostic use of cytokeratins, CD34, and neuronal cell adhesion molecule staining in focal nodular hyperplasia and hepatic adenoma.
    Ahmad I; Iyer A; Marginean CE; Yeh MM; Ferrell L; Qin L; Bifulco CB; Jain D
    Hum Pathol; 2009 May; 40(5):726-34. PubMed ID: 19157505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Different cytokeratin and neuronal cell adhesion molecule staining patterns in focal nodular hyperplasia and hepatic adenoma and their significance.
    Iyer A; Robert ME; Bifulco CB; Salem RR; Jain D
    Hum Pathol; 2008 Sep; 39(9):1370-7. PubMed ID: 18602664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Telangiectatic variant of hepatic adenoma: clinicopathologic features and correlation between liver needle biopsy and resection.
    Mounajjed T; Wu TT
    Am J Surg Pathol; 2011 Sep; 35(9):1356-63. PubMed ID: 21836491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utility of CD34 reactivity in evaluating focal nodular hepatocellular lesions sampled by fine needle aspiration biopsy.
    Kong CS; Appenzeller M; Ferrell LD
    Acta Cytol; 2000; 44(2):218-22. PubMed ID: 10740609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinction of hepatocellular carcinoma from benign hepatic mimickers using Glypican-3 and CD34 immunohistochemistry.
    Coston WM; Loera S; Lau SK; Ishizawa S; Jiang Z; Wu CL; Yen Y; Weiss LM; Chu PG
    Am J Surg Pathol; 2008 Mar; 32(3):433-44. PubMed ID: 18300806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A triple stain of reticulin, glypican-3, and glutamine synthetase: a useful aid in the diagnosis of liver lesions.
    Swanson BJ; Yearsley MM; Marsh W; Frankel WL
    Arch Pathol Lab Med; 2015 Apr; 139(4):537-42. PubMed ID: 25822763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical markers on needle biopsies are helpful for the diagnosis of focal nodular hyperplasia and hepatocellular adenoma subtypes.
    Bioulac-Sage P; Cubel G; Taouji S; Scoazec JY; Leteurtre E; Paradis V; Sturm N; Nhieu JT; Wendum D; Bancel B; Ramos J; Paraf F; Saint Paul MC; Michalak S; Fabre M; Guettier C; Le Bail B; Zucman-Rossi J; Balabaud C
    Am J Surg Pathol; 2012 Nov; 36(11):1691-9. PubMed ID: 23060349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic utility and limitations of glutamine synthetase and serum amyloid-associated protein immunohistochemistry in the distinction of focal nodular hyperplasia and inflammatory hepatocellular adenoma.
    Joseph NM; Ferrell LD; Jain D; Torbenson MS; Wu TT; Yeh MM; Kakar S
    Mod Pathol; 2014 Jan; 27(1):62-72. PubMed ID: 23807780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Podocalyxin-like protein 1 expression in primary hepatic tumours and tumour-like lesions.
    Heukamp LC; Fischer HP; Schirmacher P; Chen X; Breuhahn K; Nicolay C; Büttner R; Gütgemann I
    Histopathology; 2006 Sep; 49(3):242-7. PubMed ID: 16918970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can CD34 discriminate between benign and malignant hepatocytic lesions in fine-needle aspirates and thin core biopsies?
    de Boer WB; Segal A; Frost FA; Sterrett GF
    Cancer; 2000 Oct; 90(5):273-8. PubMed ID: 11038423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunostaining of glutamine synthetase is a sensitive and specific marker for diagnosing focal nodular hyperplasia in needle biopsy.
    Tsai JH; Jeng YM; Pan CC; Lu SW; Kuo YJ
    Pathology; 2012 Dec; 44(7):605-10. PubMed ID: 22990279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical stains of proliferating cell nuclear antigen, insulin-like growth factor 2 and clusterin help distinguish malignant from benign liver nodular lesions.
    Lai JP; Chen ZM; Lok T; Chan OT; Himmelfarb E; Zhai Q; Lin F; Wang HL
    J Clin Pathol; 2014 Jun; 67(6):464-9. PubMed ID: 24407433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunoreactivity of sinusoids in hepatocellular carcinoma. An immunohistochemical study using lectin UEA-1 and antibodies against endothelial markers, including CD34.
    Ruck P; Xiao JC; Kaiserling E
    Arch Pathol Lab Med; 1995 Feb; 119(2):173-8. PubMed ID: 7531428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatic adenoma and focal nodular hyperplasia.
    Shortell CK; Schwartz SI
    Surg Gynecol Obstet; 1991 Nov; 173(5):426-31. PubMed ID: 1658955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endothelial cell differentiation in hepatocellular adenomas: implications for histopathological diagnosis.
    Gouysse G; Frachon S; Hervieu V; Fiorentino M; d'Errico A; Dumortier J; Boillot O; Partensky C; Grigioni WF; Scoazec JY
    J Hepatol; 2004 Aug; 41(2):259-66. PubMed ID: 15288475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatocellular carcinoma, adenoma, and focal nodular hyperplasia. Comparative histopathologic study with immunohistochemical parameters.
    Koelma IA; Nap M; Huitema S; Krom RA; Houthoff HJ
    Arch Pathol Lab Med; 1986 Nov; 110(11):1035-40. PubMed ID: 2430547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnosis of focal nodular hyperplasia of the liver by needle biopsy.
    Makhlouf HR; Abdul-Al HM; Goodman ZD
    Hum Pathol; 2005 Nov; 36(11):1210-6. PubMed ID: 16260275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic challenges of focal nodular hyperplasia: interobserver variability, accuracy, and the utility of glutamine synthetase immunohistochemistry.
    Rowan DJ; Allende DS; Bellizzi AM; Gill RM; Liu X; McKenzie CA; Moreira RK; Mounajjed T; Said S; Westerhoff M; Jenkins SM; Batts KP; Burgart LJ; Lamps LW; Graham RP
    Histopathology; 2021 Nov; 79(5):791-800. PubMed ID: 34080211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatocellular adenomas in a large community population, 2000 to 2010: reclassification per current World Health Organization classification and results of long-term follow-up.
    Shafizadeh N; Genrich G; Ferrell L; Kakar S
    Hum Pathol; 2014 May; 45(5):976-83. PubMed ID: 24746201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Agrin and CD34 immunohistochemistry for the discrimination of benign versus malignant hepatocellular lesions.
    Tátrai P; Somorácz A; Batmunkh E; Schirmacher P; Kiss A; Schaff Z; Nagy P; Kovalszky I
    Am J Surg Pathol; 2009 Jun; 33(6):874-85. PubMed ID: 19194276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.